Filing Details

Accession Number:
0000929638-24-001336
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-03 17:37:04
Reporting Period:
2024-04-01
Accepted Time:
2024-04-03 17:37:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1790340 Immuneering Corp IMRX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1583977 Cormorant Asset Management, Lp 200 Clarendon Street
52Nd Floor
Boston MA 02116
No No No No
1599214 Bihua Chen C/O Cormorant Asset Management, Lp
200 Clarendon Street, 52Nd Floor
Boston MA 02116
No No No No
1618442 Cormorant Global Healthcare Master Fund, Lp 200 Clarendon Street
52Nd Floor
Boston MA 02116
No No No No
1817320 Cormorant Private Healthcare Fund Iii Lp 200 Clarendon Street
52Nd Floor
Boston MA 02116
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2024-04-01 100 $3.07 3,295,173 No 4 S Indirect See Footnote
Class A Common Stock Disposition 2024-04-01 300 $3.07 3,294,873 No 4 S Indirect See Footnote
Class A Common Stock Disposition 2024-04-01 100 $3.05 3,294,773 No 4 S Indirect See Footnote
Class A Common Stock Disposition 2024-04-01 600 $3.03 3,294,173 No 4 S Indirect See Footnote
Class A Common Stock Disposition 2024-04-01 10 $3.01 3,294,163 No 4 S Indirect See Footnote
Class A Common Stock Disposition 2024-04-01 10 $2.98 3,294,153 No 4 S Indirect See Footnote
Class A Common Stock Disposition 2024-04-01 280 $2.97 3,293,873 No 4 S Indirect See Footnote
Class A Common Stock Disposition 2024-04-01 398,600 $2.90 2,895,273 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the "Master Fund") and Cormorant Private Healthcare Fund III, LP ("Fund III"). Cormorant Global Healthcare GP, LLC ("GP LLC") and Cormorant Private Healthcare GP III, LLC ("GP III") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
  2. Represents (i) 1,087,655 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,207,518 shares of Class A Common Stock beneficially owned by Fund III.
  3. Represents (i) 1,087,556 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,207,317 shares of Class A Common Stock beneficially owned by Fund III.
  4. Represents (i) 1,087,523 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,207,250 shares of Class A Common Stock beneficially owned by Fund III.
  5. Represents (i) 1,087,325 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,206,848 shares of Class A Common Stock beneficially owned by Fund III.
  6. Represents (i) 1,087,322 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,206,841 shares of Class A Common Stock beneficially owned by Fund III.
  7. Represents (i) 1,087,319 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,206,834 shares of Class A Common Stock beneficially owned by Fund III.
  8. Represents (i) 1,086,227 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,206,646 shares of Class A Common Stock beneficially owned by Fund III.
  9. Represents (i) 955,689 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 1,939,584 shares of Class A Common Stock beneficially owned by Fund III.